For: | Hirahara I, Kusano E, Morishita Y, Inoue M, Akimoto T, Saito O, Muto S, Nagata D. Matrix metalloproteinase-2 as a superior biomarker for peritoneal deterioration in peritoneal dialysis. World J Nephrol 2016; 5(2): 204-212 [PMID: 26981446 DOI: 10.5527/wjn.v5.i2.204] |
---|---|
URL: | https://www.wjgnet.com/2220-6124/full/v5/i2/204.htm |
Number | Citing Articles |
1 |
Takuya Ishimura, Akira Ishii, Hiroyuki Yamada, Keisuke Osaki, Naohiro Toda, Keita P. Mori, Shoko Ohno, Yukiko Kato, Takaya Handa, Sayaka Sugioka, Akie Ikushima, Haruomi Nishio, Motoko Yanagita, Hideki Yokoi. Matrix metalloproteinase-10 deficiency has protective effects against peritoneal inflammation and fibrosis via transcription factor NFκΒ pathway inhibition. Kidney International 2023; 104(5): 929 doi: 10.1016/j.kint.2023.08.010
|
2 |
Dirk G. Struijk, Ramesh Khanna. Nolph and Gokal's Textbook of Peritoneal Dialysis. 2021; : 1 doi: 10.1007/978-3-319-90760-4_15-1
|
3 |
Dirk G. Struijk, Ramesh Khanna. Nolph and Gokal's Textbook of Peritoneal Dialysis. 2023; : 361 doi: 10.1007/978-3-030-62087-5_15
|
4 |
Peter J. Margetts. Matrix metalloproteinase 10 and the slow demise of the peritoneal membrane. Kidney International 2023; 104(5): 880 doi: 10.1016/j.kint.2023.09.009
|